[1. van der Most PJ, Dolga A,Nijholt I, Luiten P, Eisel U. Statins: Mechanisms of neuroprotection. Prog Neurobiol. 2009;88(l):64-75.10.1016/j.pneurobio.2009.02.00219428962]Search in Google Scholar
[2. Masse I, Beordet R, Deplanque D, A1K, Richard F, Libersa et al. Lipid lowering drugs are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005; 76(12): 1624-9.10.1136/jnnp.2005.063388173946616291883]Search in Google Scholar
[3. Jick H, Zomberg GL, Jick S, Seshadri S, Drachman DA. Statins and the risk of dementia, The Lancet. 2000;356:1627-31.]Search in Google Scholar
[4. Bemick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology. 2005;65(9): 1388-94.10.1212/01.wnl.0000182897.18229.ec16275825]Search in Google Scholar
[5. Parle M, Singh N. Reversal of memory deficits by Atorvastatin and Simvastatin in Rats. Yakugaku Zasshi. 2007; 127(7): 1125-37.10.1248/yakushi.127.112517603272]Search in Google Scholar
[6. Evans MA, Golomb BA, Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29(7):800-l 1.10.1592/phco.29.7.80019558254]Search in Google Scholar
[7. Padala KP, Padala PR, Potter JF, Simvastatin-induced decline in cognition, Ann Pharmacother. 2006;40( 10): 1880-3.10.1345/aph.1H01416940411]Search in Google Scholar
[8. Kalonia H, Kumar P, Kumar A. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats. Behav Brain Res. 2011;216(1): 220-8.10.1016/j.bbr.2010.07.04020696189]Search in Google Scholar
[9. Wang H, Lynch JR, Song P, Yang HJ, Yates RB, Mace B, et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol. 2007;206(1): 56-69.10.1016/j.expneurol.2007.03.03117521631]Search in Google Scholar
[10. Ucak A, Onan B, Guler A, Sahin MA, KihqkayaO, Oztaș E, et al. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfesion-induced spinal cord tissue injury in rats. Ann Vase Surg. 2011;25(5):686-95.10.1016/j.avsg.2011.02.02421724106]Search in Google Scholar
[11. Baytan SH, Alkanat M, Okuyan M, Ekinci M, Gedikli E, Ozeren M, et al. Simvastatin impairs spatial memory in rats at a specific dose level. Tohoku J Exp Med. 2008;214(4):341 -9.10.1620/tjem.214.34118441510]Search in Google Scholar
[12. Baytan SH, Alkatan M, Ozeren M, Ekinci M, Akgun A. Fluvastatin alters psychomotor performance and daily activity but not the spatial memory in rats. Tohoku J Exp Med. 2006,209(4), 311-20.]Search in Google Scholar
[13. Douma TN, Borre Y, Hendriksen H, Olivier B, Oosting RS. Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats. Psychopharmacology. 2011 ;216(4):537-44.10.1007/s00213-011-2245-0]Search in Google Scholar
[14. Vaughan CJ. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol.2003;91(4A):23B-29B.10.1016/S0002-9149(02)03270-8]Search in Google Scholar
[15. Wang Q, Zengin A, Deng C, Li Y, Newell KA, Yang GY, et al. High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: the association with the upregulation of NMDA receptor binding in the rat brain. Exp Neurol. 2009;216( 1): 132-8.10.1016/j.expneurol.2008.11.016]Search in Google Scholar
[16. Magnusson KR, Cotman C W. Effects of aging on NMDAnand MK801 binding sites in mice. Brain Res. 1993 ;604( 1 -2) :334-7.10.1016/0006-8993(93)90386-2]Search in Google Scholar
[17. Malenka RC, Nicoll RA. Long-term potentiation-a decade of progress? Science 1999; 285(5435): 1870-4. ]Search in Google Scholar